Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4088285
Max Phase: Preclinical
Molecular Formula: C14H18N4OS
Molecular Weight: 290.39
Molecule Type: Small molecule
Associated Items:
ID: ALA4088285
Max Phase: Preclinical
Molecular Formula: C14H18N4OS
Molecular Weight: 290.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)SCC(CCCc1ccccc1)c1nnn[nH]1
Standard InChI: InChI=1S/C14H18N4OS/c1-11(19)20-10-13(14-15-17-18-16-14)9-5-8-12-6-3-2-4-7-12/h2-4,6-7,13H,5,8-10H2,1H3,(H,15,16,17,18)
Standard InChI Key: UBDGPNCDIDTRMO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 290.39 | Molecular Weight (Monoisotopic): 290.1201 | AlogP: 2.59 | #Rotatable Bonds: 7 |
Polar Surface Area: 71.53 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.36 | CX Basic pKa: | CX LogP: 2.87 | CX LogD: 1.28 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -0.71 |
1. Skagseth S, Akhter S, Paulsen MH, Muhammad Z, Lauksund S, Samuelsen Ø, Leiros HS, Bayer A.. (2017) Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding., 135 [PMID:28445786] [10.1016/j.ejmech.2017.04.035] |
Source(1):